BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 16860939)

  • 41. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
    Hsu CH; Chen MY; Cheng AL
    Anticancer Res; 2000; 20(2B):1159-61. PubMed ID: 10810414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
    Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
    Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AIDS-related Kaposi's sarcoma: current treatment options, future trends.
    Mitsuyasu RT
    Oncology (Williston Park); 2000 Jun; 14(6):867-78; discussion 878, 881-3, 887-. PubMed ID: 10887636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapidly eruptive, treatment-resistant, nodular Kaposi's sarcoma in an acquired immunodeficiency syndrome (AIDS) patient on highly active antiretroviral therapy.
    Chang CA; Sanchez MR; Karen JK; Rosenman KS; Prystowsky SD
    Int J Dermatol; 2009 Feb; 48(2):173-4. PubMed ID: 19200196
    [No Abstract]   [Full Text] [Related]  

  • 45. [AIDS-associated Kaposi's sarcoma: 22 cases].
    Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
    Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KS treatment inches forward.
    Vazquez E
    Posit Aware; 1996; 7(5):9. PubMed ID: 11363790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kaposi's sarcoma in patients infected with human virus (HIV): an overview.
    Hermans P; Clumeck N
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):357-64. PubMed ID: 7580828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy.
    Aboulafia DM
    Mayo Clin Proc; 1998 May; 73(5):439-43. PubMed ID: 9581584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma.
    Krown SE
    J Clin Oncol; 2004 Feb; 22(3):399-402. PubMed ID: 14752065
    [No Abstract]   [Full Text] [Related]  

  • 52. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.
    Dezube BJ; Krown SE; Lee JY; Bauer KS; Aboulafia DM
    J Clin Oncol; 2006 Mar; 24(9):1389-94. PubMed ID: 16549833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent advances in the treatment of AIDS-related Kaposi's sarcoma.
    Cattelan AM; Trevenzoli M; Aversa SM
    Am J Clin Dermatol; 2002; 3(7):451-62. PubMed ID: 12180893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wide-ranging progress on KS therapies.
    Horn T; Gilden D
    GMHC Treat Issues; 1998 Feb; 12(2):8-16. PubMed ID: 11365219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overview of the management of AIDS-related Kaposi's sarcoma.
    Morris AK; Valley AW
    Ann Pharmacother; 1996 Oct; 30(10):1150-63. PubMed ID: 8893123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical, biologic, and therapeutic aspects of malignancies associated with the acquired immunodeficiency syndrome: Part I and Part II.
    Steis RG; Longo DL
    Ann Allergy; 1988 Apr; 60(4):310-23. PubMed ID: 2451890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AIDS-related Kaposi's sarcoma: a review.
    Stein M; Spencer D; Kuten A; Bezwoda W
    Isr J Med Sci; 1994 Apr; 30(4):298-305. PubMed ID: 8175336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma.
    Stebbing J; Sanitt A; Teague A; Powles T; Nelson M; Gazzard B; Bower M
    J Clin Oncol; 2007 Jun; 25(16):2230-5. PubMed ID: 17470847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral HIV-associated Kaposi sarcoma.
    Pantanowitz L; Khammissa RA; Lemmer J; Feller L
    J Oral Pathol Med; 2013 Mar; 42(3):201-7. PubMed ID: 22672182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa.
    Sissolak G; Mayaud P
    Trop Med Int Health; 2005 Oct; 10(10):981-92. PubMed ID: 16185232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.